English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals

Kreer, C., Lupo, C., Ercanoglu, M., Gieselmann, L., Spisak, N., Grossbach, J., et al. (2023). Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals. Nature Communications, 14(1): 7137. doi:10.1038/s41467-023-42906-y.

Item is

Files

show Files
hide Files
:
s41467-023-42906-y.pdf (Publisher version), 32MB
Name:
s41467-023-42906-y.pdf
Description:
-
OA-Status:
Gold
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
-
Copyright Info:
-

Locators

show

Creators

show
hide
 Creators:
Kreer, C., Author
Lupo, C., Author
Ercanoglu, M.S., Author
Gieselmann, L., Author
Spisak, N., Author
Grossbach, J., Author
Schlotz, M., Author
Schommers, P., Author
Gruell, H., Author
Dold, L., Author
Beyer, A., Author
Nourmohammad, Armita1, Author           
Mora, T., Author
Walczak, A.M., Author
Klein, F., Author
Affiliations:
1Max Planck Research Group Statistical physics of evolving systems, Max Planck Institute for Dynamics and Self-Organization, Max Planck Society, ou_2516692              

Content

show
hide
Free keywords: -
 Abstract: HIV-1 broadly neutralizing antibodies (bNAbs) are able to suppress viremia and prevent infection. Their induction by vaccination is therefore a major goal. However, in contrast to antibodies that neutralize other pathogens, HIV-1-specific bNAbs frequently carry uncommon molecular characteristics that might prevent their induction. Here, we perform unbiased sequence analyses of B cell receptor repertoires from 57 uninfected and 46 chronically HIV-1- or HCV-infected individuals and learn probabilistic models to predict the likelihood of bNAb development. We formally show that lower probabilities for bNAbs are predictive of higher HIV-1 neutralization activity. Moreover, ranking bNAbs by their probabilities allows to identify highly potent antibodies with superior generation probabilities as preferential targets for vaccination approaches. Importantly, we find equal bNAb probabilities across infected and uninfected individuals. This implies that chronic infection is not a prerequisite for the generation of bNAbs, fostering the hope that HIV-1 vaccines can induce bNAb development in uninfected people.

Details

show
hide
Language(s): eng - English
 Dates: 2023-11-062023
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1038/s41467-023-42906-y
 Degree: -

Event

show

Legal Case

show

Project information

show hide
Project name : STRUGGLE
Grant ID : 724208
Funding program : Horizon 2020 (H2020)
Funding organization : European Commission (EC)
Project name : HIV1ABTHERAPY
Grant ID : 639961
Funding program : Horizon 2020 (H2020)
Funding organization : European Commission (EC)

Source 1

show
hide
Title: Nature Communications
  Abbreviation : Nat. Commun.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: London : Nature Publishing Group
Pages: - Volume / Issue: 14 (1) Sequence Number: 7137 Start / End Page: - Identifier: ISSN: 2041-1723
CoNE: https://pure.mpg.de/cone/journals/resource/2041-1723